These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Synthesis of bridged piperazines with sigma receptor affinity.
    Author: Weigl M, Wünsch B.
    Journal: Eur J Med Chem; 2007 Oct; 42(10):1247-62. PubMed ID: 17420073.
    Abstract:
    Bridged piperazines 4 were designed as conformationally restricted piperazine sigma receptor ligands. The chiral pool synthesis started from (S)-glutamate, which was transformed in five reaction steps into the piperazinediones 5 bearing a propionic acid ester side chain. A two-step Dieckmann analogous cyclization provided the bicyclic ketones 7 as key intermediates. The alcohols 8 were prepared by LiAlH4 reduction of the ketones 7. NaBH4 reduction, Williamson ether synthesis and LiAlH4 reduction led to the methyl and benzyl ethers 12 and 13. High sigma1 affinity is attained when one large substituent is introduced either at N-8 or O-2. The most potent sigma1 ligand in this series of compounds is the methyl ether 12b with the N-butyl substituent (K(i)=13.2 nM, selectivity sigma2:sigma1 = 16). Moreover, the N-methyl derivatives 13a (sigma2: K(i)=30.4 nM) and 12a (sigma2 preference) represent promising starting points for the development of potent and selective sigma2 ligands.
    [Abstract] [Full Text] [Related] [New Search]